Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01640366 · ClinicalTrials.gov registry record · NA
PICO Breast Reduction Clinical Study Looking at Incision Healing Complications
A NA study of Delayed Healing, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 6
- Study locations
NCT01640366 is a NA study of Delayed Healing that has completed, run by Smith & Nephew. The registered enrollment target is 200 participants. The trial reports 6 study locations across 4 states.
The verdict
NCT01640366, a NA study of Delayed Healing, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to see if the use of a single-use negative pressure wound therapy system (NPWT) will have an effect on the reduction of post-surgical incision healing complications following breast reduction surgery and to assess the medium-term aesthetic appearance and quality of the resultant scar, compared with standard of care dressings.
Conditions Studied
Interventions
- DEVICE PICO
Study Locations (6)
Other
- CHU de Nantes Hôtel Dieu - Nantes
- Academisch Ziekenhuis Maastricht (AZM) - Maastricht
- University of Cape Town - Cape Town
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
New York
- Montefiore - The Bronx
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01640366
The ClinicalTrials.gov registry entry for NCT01640366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Delayed Healing appearing as the primary indexed condition, and to 1 intervention - of which PICO is the first listed.
NCT01640366 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT01640366 about?
NCT01640366 is a clinical study titled "PICO Breast Reduction Clinical Study Looking at Incision Healing Complications". The purpose of this study is to see if the use of a single-use negative pressure wound therapy system (NPWT) will have an effect on the reduction of post-surgical incision healing complications following breast reduction surgery and to assess the medium-term aesthetic appearance and quality of the r...
What is the current status of trial NCT01640366?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-06. Estimated completion is 2014-07.
What conditions does trial NCT01640366 study?
This clinical trial studies the following conditions: Delayed Healing.
What interventions are being tested in trial NCT01640366?
The interventions under investigation include: PICO (DEVICE).
Who is sponsoring clinical trial NCT01640366?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01640366 being conducted?
This trial has 6 study locations across Illinois, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.